Sohrab Z. Khan
Sohrab Z. Khan
Sarepta Therapeutics
Verified email at
Cited by
Cited by
Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication
JK Ahluwalia, SZ Khan, K Soni, P Rawat, A Gupta, M Hariharan, V Scaria, ...
Retrovirology 5, 1-10, 2008
Measuring glutathione redox potential of HIV-1-infected macrophages
A Bhaskar, MH Munshi, SZ Khan, S Fatima, R Arya, S Jameel, A Singh
Journal of Biological Chemistry 290 (2), 1020-1038, 2015
Reciprocal regulation of human immunodeficiency virus-1 gene expression and replication by heat shock proteins 40 and 70
M Kumar, P Rawat, SZ Khan, N Dhamija, P Chaudhary, DS Ravi, D Mitra
Journal of molecular biology 410 (5), 944-958, 2011
Testing Preexisting Antibodies Prior to AAV Gene Transfer Therapy: Rationale, Lessons and Future Considerations
LRRK Jerry R. Mendell, Anne M. Connolly, Kelly J. Lehman, Danielle A ...
Molecular Therapy - Methods & Clinical Development, 2022
HSP70 binding protein 1 (HspBP1) suppresses HIV-1 replication by inhibiting NF-κB mediated activation of viral gene expression
P Chaudhary, SZ Khan, P Rawat, T Augustine, DA Raynes, V Guerriero, ...
Nucleic acids research 44 (4), 1613-1629, 2016
Apoptosis-induced activation of HIV-1 in latently infected cell lines
SZ Khan, N Hand, SL Zeichner
Retrovirology 12, 1-19, 2015
Targeting IκB proteins for HIV latency activation: The role of individual IκB and NF-κB proteins.
Guerau Fernandez, Thomas D. Zaikos, Sohrab Z. Khan
Journal of Virology, 2013
Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent manner
SZ Khan, D Mitra
Journal of Biological Chemistry 286 (26), 22943-22954, 2011
Risk for HIV-1 infection is not associated with repeat-region polymorphism in the DC-SIGN neck domain and novel genetic DC-SIGN variants among North Indians
A Rathore, A Chatterjee, V Sood, SZ Khan, AC Banerjea, N Yamamoto, ...
Clinica Chimica Acta 391 (1-2), 1-5, 2008
Nuclear transit and HIV LTR binding of NF-κB subunits held by IκB proteins: implications for HIV-1 activation
SZ Khan, S Gasperino, SL Zeichner
Viruses 11 (12), 1162, 2019
AAV-based CRISPR-Cas9 genome editing: challenges and engineering opportunities
AM Kabadi, MK Mejia-Guerra, JD Graef, SZ Khan, EM Walton, X Wang, ...
Current Opinion in Biomedical Engineering, 100517, 2023
Host genes that affect progression of AIDS/HIV in India and novel gene therapeutic approaches against HIV
V Sood, A Rathore, S Husain, S Khan, S Patra, V Shankar, H Kumar, ...
CSIR, 2008
Cyclin K inhibits HIV-1 gene expression and replication by interfering with CDK9-cyclin T1 interaction in Nef dependent manner
SZ Khan, D Mitra
J. Biol. Chem 286, 22943-22954, 2011
T-cell response to micro-dystrophin in a patient treated with delandistrogene moxeparvovec gene therapy: A case of immune-mediated myositis (P. 54)
S Khan, H Haegel, A Hollenstein, C Wandel, D Asher, DA Griffin, ...
World Muscle Society (WMS), 2023
Adeno-associated virus antibodies and fragments thereof
K Sohrab, D Griffin, L Rodino-Klapac
US Patent App. 17/348,356, 2021
P17 Safety and efficacy of pre-treatment with imlifidase prior to AAV-based gene therapy in non-human primates with pre-existing anti-AAVrh74 antibodies
R Potter, S Khan, J Snedeker, K Adegboye, A Haile, B Sayanjali, N Pukos, ...
Neuromuscular Disorders 33, S101, 2023
P54 T-cell response to SRP-9001 dystrophin transgene in a patient treated with Delandistrogene Moxeparvovec: a case of immune-mediated myositis
S Khan, H Haegel, A Hollenstein, C Wandel, K Wagner, D Asher, D Griffin, ...
Neuromuscular Disorders 33, S72, 2023
S Khan, D Griffin, L Rodino-Klapac
US Patent US 11,472,866 B2, 2022
P-B1 Apoptosis-mediated HIV reactivation
S Khan, S Zeichner
JAIDS Journal of Acquired Immune Deficiency Syndromes 67, 82, 2014
Human miRNAs: an antiviral defense mechanism
K Soni, JK Ahluwalia, SZ Khan, B Pillai, D Mitra, SK Brahmachari
Retrovirology 6 (Suppl 2), P83, 2009
The system can't perform the operation now. Try again later.
Articles 1–20